Navigation Links
Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy'

le were removed. Calculations based on the original data indicate that children with autism "were 71% more likely to have been exposed to RhIg in utero than their non-ASD siblings," according to the SafeMinds analysis.

NAA's Fournier points out that the RhIg study fits a recurring pattern for thimerosal research with drug company/researcher ties. Manipulation of data to reach a desired conclusion was seen in CDC studies conducted in 2000 showing a relationship between thimerosal-containing vaccines and a range of adverse neurological effects including autism. The data was manipulated to lower the relative risk factor before publication in the journal Pediatrics in 2004. Lead investigator Dr. Thomas Verstraeten left the CDC to work for vaccine maker Glaxo-Smith-Kline in 2001 while the data alterations were ongoing, but his employment was not disclosed by the journal. Likewise, Dr. Michael Pichichero, an Eli Lilly-funded researcher and holder of numerous vaccine patents, tried to clear thimerosal as harmful by conducting a blood mercury evaluation after infant vaccination which missed peak blood levels, had a sample size too small to detect susceptible subgroups, and failed to address implications of the findings for long term mercury deposition in the brain. His industry ties were not disclosed by the journal, The Lancet.

"While this latest RhIg effort is the best science drug money can buy," points out Ms. Fournier, "NAA feels that the public and families with autism deserve better quality studies. This is a critical product safety issue." RhIg is given to approximately 15% of all pregnant women.

To read the entire analysis, go to http://www.safeminds.org. For more about autism, visit http://www.nationalautism.org.

Contacts:

Rita Shreffler (Nixa, MO) 401-632-6452

Wendy Fournier (Portsmouth, RI) 401-632-7523<
'"/>




Page: 1 2 3

Related medicine technology :

1. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
2. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
3. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
4. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
5. Myriad Genetics Presents Tumor Origin Technology at AACR
6. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
7. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
8. Myriad Genetics Presents Azixas Mode of Action at AACR
9. Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer
10. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
11. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology

Post Your Comments:
(Date:11/8/2009)...e Passage of Health Care Reform Bill ,, Criti... coverage for all Americans ,, BOISE, Idaho, ...d States House of Representatives passed critical ...en Medicare for seniors and end discrimination by ...ans out of affordable health coverage. ,, The...
(Date:11/7/2009)... Nov. 7 Patients reported C1-ester... therapy in treating acute swelling attacks at any... disorder, according to data presented today at th...mmunology (ACAAI) Annual Meeting. The results come... in parallel with the ongoing, prospective, open l...
(Date:11/7/2009)... Nov. 7 Most patients with heredit...signal an oncoming HAE attack giving the patients ... the morbidity associated with that attack, accord... American College of Allergy, Asthma & Immunol...ymptoms such as fatigue and nausea, which occur fr...
Breaking Medicine Technology:AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3Zoo volunteers help explain mysteries of the genome 9810 1Zoo volunteers help explain mysteries of the genome 9810 2Zoo volunteers help explain mysteries of the genome 9810 3Researchers find 2 more genetic risk factors for Alzheimers disease 9806 1Researchers find 2 more genetic risk factors for Alzheimers disease 9806 2Kickoff Punting Take a Toll 56326 1Kickoff Punting Take a Toll 56326 2
...25 Findings from an international,multicenter, ra... trial,evaluating ustekinumab (CNTO 1275) in the t...ll be presented for the first time at the 21st mee...akes place from Sept. 30 to,Oct. 5, 2007 in Buenos...O 1275 (anti-IL-12/23p40) Treatment of,Psoriasis: ...
...Drug,s Benefit, Alone and With Lipitor(R), in, O...and Triglycerides -, HAYWARD, Calif., Sept. 25 M...to the discovery and development of novel,therapeu... announced today,that it has begun a 180-patient P...tients with high cholesterol and triglycerides to ...
Other Medicine Technology:Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting 2Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia 2
(Date:11/8/2009)...osts and Crushing Taxes Nail Nation,s Job Creators...-- In response to U.S. House passage of the health...preneurship Council (SBE Council) president & ... ,, "Make no mistake, those voting for H.R. 39...higher costs and crushing taxes and penalties. Eve...
(Date:11/8/2009)...ON, Nov. 8 Speaker Nanc...rence following the House passage of H.R. 3962, th...l passed by a vote of 220 to 215. Below are the S... colleagues just received a call from the Presiden...ng us on a great victory for the American people. ...
(Date:11/8/2009)...ON, Nov. 7 Tonight the ...lth Care for America Act, landmark health reform l...ess to quality, affordable, stable and secure heal...wn on some of the insurance industry,s worst pract...s and cut the deficit by $104 billion over ten yea...
(Date:11/8/2009)... New book called "Preventing and H.... Roberto Giraldo shows that AIDS is a result of m...y of so-called immune system stressor agents, whic...d most of all, emotional. , ...ov. 6 – 8, 2009, cell biologists, physicians...
(Date:11/8/2009)... 3D Global Solutions is pleased to anno...ng the proposal effort for ReSound who recently re...ring Aid contract. The award includes not only the...of Defense and other federal agencies. , ...009 -- 3D Global Solutions is pleased to announce ...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3
...N, Feb. 6 The U.S. Agency for,International Devel...y of,Zero Tolerance for Female Genital Cutting (FG... First Lady of the Federal Republic of Nigeria,spe...practice., Approximately 100 million to 140 milli...
...IS, Feb. 6 Worrell Inc., a full-service,product d...Shanghai, has,acquired the Montreal and San Diego ...ges Worrell Inc.,s industrial design prowess with ...ell. "We know how this business works. The Gad,Sha...
... currently expected to be February 21, 2008 ...ceived - Class action lawsuit settled...n Therapy,Services, Inc. (Nasdaq: RTSX ) (the "Co...d as of October 19, 2007 among,the Company, Radiat...
...f the Red Cross Annual Disaster Giving Program Pro...re weather and,tornadoes ripped through the South ...ommunities in Arkansas, Kentucky, Tennessee, Alaba...shelter, feeding victims and search and rescue wor...
..., Mass. (February 6, 2008)Perhaps the only positiv...a is that its relatively uncommon. Other than that...ends to strike people in the prime of their lives,...is poorly understood type of cancer. , One appro...
...N, Feb. 6 The Lupus Foundation of,America (LFA) i...atient,education series. Five new booklets and ele... information about lupus diagnosis and treatment.,... individuals and families. Developed in consultati...
Other Medicine News:Health News:From Kent Hill, USAID Assistant Administrator for Global Health on the Observance of International Day of Zero Tolerance 2Health News:Radiation Therapy Services, Inc. Shareholders Approve Merger Agreement 2Health News:Radiation Therapy Services, Inc. Shareholders Approve Merger Agreement 3Health News:American Red Cross Responds to Tornadoes in the Southeast 2Health News:Gene plays 'Jekyll and Hyde' in brain cancer 2Health News:Gene plays 'Jekyll and Hyde' in brain cancer 3Health News:Lupus Foundation of America Releases New Patient Education Series 2
...he widest offering of single-use instruments on th...long 43cm lengths for Bariatric Surgery. , Dual a...sulation covers the pivot points to reduce the cha...cord, which eliminates gapping at connection and t...
MultAcoice™™ Rongeur Handle With Ratchet and Monopolar Cautery
MultAcoice™ 5 mm Insulated Outer Shaft
...order products are offered as 1-piece or modular, ...ruments may be customized with handles of choice a...flush ports. Many standard patterns are available ...ffect delivery times. , Please Note: Individual ...
Medicine Products: